Haemonetics (HAE) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $77.40 -0.81%
Revenue Growth %: +2.3%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OVLY, UTMD, AMBZ, More
Revenue Growth %: +2.3%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
OVLY, UTMD, AMBZ, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.31, $0.06 better than the analyst estimate of $1.25. Revenue for the quarter came in at $338.97 million versus the consensus estimate of $331.91 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SLM (SLM) Misses Q2 EPS by 16c; offers guidance
- Isabella Bank Corporation (ISBA) Misses Q2 EPS by 23c
- Phillips Edison & Company (PECO) Tops Q2 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
